World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
30022
World Ranking
1952
National Ranking
956

Overview

Andrew H. Lichtman is affiliated with Brigham and Women's Hospital in the United States. Their research spans multiple fields including Medicine and Immunology and Microbiology, with a strong emphasis on subfields such as Immunology, Infectious Diseases, Epidemiology, Oncology, and Hepatology.

The scientist's work encompasses key topics within immunology and disease research, focusing extensively on:

  • Atherosclerosis and Cardiovascular Diseases
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Hepatitis B Virus Studies
  • Hepatitis C virus research

Frequent publication venues for Lichtman include journals with a focus on immunological and clinical research such as:

  • Science Immunology
  • Zeitschrift für Gastroenterologie
  • Atherosclerosis
  • Diabetes
  • The Journal of Immunology

The scientist collaborates regularly with a number of co-authors, which include:

  • Vijayashree Mysore
  • Xavier Culleré
  • Daniel Engelbertsen
  • Pietro Andreoné
  • Olga Sagalova

Among recent published papers, Lichtman's associated works include:

  • "Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms," 2021, Journal of Clinical Investigation
  • "FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity," 2021, Nature Communications
  • "Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens," 2021, Med
  • "Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart," 2024, Nature Reviews Cancer
  • "LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice," 2022, JACC CardioOncology

Best Publications

  • Cellular and Molecular Immunology

    Abul K. Abbas;Andrew H. Lichtman;Shiv Pillai

  • Fulminant Myocarditis with Combination Immune Checkpoint Blockade

    Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias

  • Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

    Peter Libby;Andrew H. Lichtman;Göran K. Hansson

  • Cutting Edge: Heat Shock Protein (HSP) 60 Activates the Innate Immune Response: CD14 Is an Essential Receptor for HSP60 Activation of Mononuclear Cells

    Amir Kol;Andrew H. Lichtman;Robert W. Finberg;Peter Libby

  • Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages

    Amir Kol;Todd Bourcier;Andrew Harry Lichtman;Peter Libby

  • NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

    Jonathan D. Brown;Charles Y. Lin;Qiong Duan;Qiong Duan;Gabriel Griffin

  • Monocyte-Macrophages and T Cells in Atherosclerosis

    Ira Tabas;Andrew H. Lichtman

  • Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus.

    Roberto Bonasio;M Lucila Scimone;Patrick Schaerli;Nir Grabie

  • T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

    Chiara Buono;Christoph J. Binder;George Stavrakis;Joseph L. Witztum

  • In Vivo High Resolution Three-Dimensional Imaging of Antigen-Specific Cytotoxic T-Lymphocyte Trafficking to Tumors

    Moritz F. Kircher;Jennifer R. Allport;Edward E. Graves;Victoria Love

  • Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.

    Nancy Rodig;Timothy Ryan;Jessica A Allen;Hong Pang

  • IL-17 and TNF-α Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial Activation

    Gabriel K. Griffin;Gail Newton;Margarite L. Tarrio;De Xiu Bu;De Xiu Bu

  • Mouse Eotaxin Expression Parallels Eosinophil Accumulation during Lung Allergic Inflammation but It Is Not Restricted to a Th2-Type Response

    J. A. Gonzalo;G. Q. Jia;V. Aguirre;D. Friend

  • The Influence of Innate and Adaptive Immune Responses on Atherosclerosis

    Joseph L. Witztum;Andrew H. Lichtman

  • Role of interleukin 1 in the activation of T lymphocytes

    Andrew H. Lichtman;Jayne Chin;John A. Schmidt;Abul K. Abbas

  • T-bet is required for optimal proinflammatory CD4+ T-cell trafficking.

    Graham M. Lord;Ravi M. Rao;Hyeryun Choe;Brandon M. Sullivan

  • PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis

    Margarite L. Tarrio;Nir Grabie;De-xiu Bu;Arlene H. Sharpe;Arlene H. Sharpe

  • Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8+ T-Cell–Mediated Injury in the Heart

    Nir Grabie;Israel Gotsman;Rosa DaCosta;Hong Pang

  • P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow.

    Francis W. Luscinskas;Han Ding;Andrew H. Lichtman

  • Mechanisms for the Anti-Inflammatory Effects of Statins

    De-xiu Bu;Gabriel Griffin;Andrew H Lichtman

  • Basic Immunology : Functions and Disorders of the Immune System

    Abul K. Abbas;Andrew H. Lichtman

Frequent Co-Authors

Abul K. Abbas
Abul K. Abbas University of California, San Francisco
Francis W. Luscinskas
Francis W. Luscinskas Brigham and Women's Hospital
Arlene H. Sharpe
Arlene H. Sharpe Harvard University
James A. Lederer
James A. Lederer Brigham and Women's Hospital
Peter Libby
Peter Libby Brigham and Women's Hospital
Laurie H. Glimcher
Laurie H. Glimcher Harvard University
Marshall A. Lichtman
Marshall A. Lichtman University of Rochester Medical Center
Joseph L. Witztum
Joseph L. Witztum University of California, San Diego
Galina K. Sukhova
Galina K. Sukhova Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with fields like nursing and healthcare management. For those interested in advancing clinical practice, exploring online pmhnp programs with clinical placement can be a valuable step. These programs blend convenience with essential hands-on experience, which is crucial in clinical immunology and patient care.

Cost is a significant consideration when selecting a program. Investigating the cheapest pmhnp programs can make advanced education more accessible, helping students manage finances while gaining expertise relevant to immunology-related healthcare roles.

Career progression in immunology-related nursing can lead to roles that require a Doctor of Nursing Practice (DNP) degree. Understanding the doctor of nursing practice salary across states helps prospective students evaluate the return on investment for advanced degrees in this field.

For licensed family nurse practitioners, transitioning to more specialized roles is possible through certifications. Learning how to make the fnp to acute care certification transition allows nurses to work in acute immunology care settings, further expanding career opportunities.

Best Scientists Citing Andrew H. Lichtman

Trending Scientists